Effect of thalidomide on MCP-1 in synovial joints of rats
Lisha Wang
Abstract
Lisha Wang
Abstract
Objective To observe the effect of thalidomide on MCP-1 in synovial joints of rats. MethodsA CIA model of Wistar rats was established by injecting bovine II collagen(BIIC) . The rats were randomly divided into normal control group,CIA control group,indometacin group and thalidomide group. ResultsThe CIA model was successfully established 11-13 days after injection of BIIC. The swelling of joints reached its peak 17 days after injection of thalidomide and was milder in thalidomide group. Thalidomide significantly ameliorated the symptoms of CIA rats,inhibited swelling of joints,and reduced inflammatory invasion and expression of MCP-1. ConclusionThe anti-inflammatory action of thalidomide is related to the expression of MCP-1.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of thalidomide on MCP-1 in synovial joints of rats. MethodsA CIA model of Wistar rats was established by injecting bovine II collagen(BIIC) . The rats were randomly divided into normal control group,CIA control group,indometacin group and thalidomide group. ResultsThe CIA model was successfully established 11-13 days after injection of BIIC. The swelling of joints reached its peak 17 days after injection of thalidomide and was milder in thalidomide group. Thalidomide significantly ameliorated the symptoms of CIA rats,inhibited swelling of joints,and reduced inflammatory invasion and expression of MCP-1. ConclusionThe anti-inflammatory action of thalidomide is related to the expression of MCP-1.
Key concepts: Thalidomide, Medicine, Pharmacology, Internal medicine, Multiple myeloma